Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.

Crespo, Elena

Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. [electronic resource] - Kidney international 07 2017 - 201-213 p. digital

Publication Type: Journal Article; Validation Study

1523-1755

10.1016/j.kint.2016.12.024 doi


Adult
Aged
Area Under Curve
Asymptomatic Diseases
Biomarkers--blood
Biopsy
Chi-Square Distribution
Cross-Sectional Studies
Diagnosis, Differential
Enzyme-Linked Immunospot Assay
Female
Graft Rejection--blood
HLA Antigens--immunology
Histocompatibility
Humans
Immunity, Cellular
Interferon-gamma--blood
Interferon-gamma Release Tests
Isoantibodies--blood
Kidney Transplantation--adverse effects
Logistic Models
Male
Middle Aged
Monitoring, Immunologic--methods
Multivariate Analysis
Odds Ratio
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
ROC Curve
Risk Factors
T-Lymphocytes--immunology
Treatment Outcome